ES2184650B1 - USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. - Google Patents

USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS.

Info

Publication number
ES2184650B1
ES2184650B1 ES200102260A ES200102260A ES2184650B1 ES 2184650 B1 ES2184650 B1 ES 2184650B1 ES 200102260 A ES200102260 A ES 200102260A ES 200102260 A ES200102260 A ES 200102260A ES 2184650 B1 ES2184650 B1 ES 2184650B1
Authority
ES
Spain
Prior art keywords
treatment
cholesterol
leishmaniasis
phospholipids
canidos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200102260A
Other languages
Spanish (es)
Other versions
ES2184650A1 (en
Inventor
Aida Lacasa Mas
Joan Cunill Aixela
Diana Lacasa Mas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FARMALEIS SL
Original Assignee
FARMALEIS SL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FARMALEIS SL filed Critical FARMALEIS SL
Priority to ES200102260A priority Critical patent/ES2184650B1/en
Publication of ES2184650A1 publication Critical patent/ES2184650A1/en
Application granted granted Critical
Publication of ES2184650B1 publication Critical patent/ES2184650B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

Utilización de colesterol y fosfolípidos en medicamentos para el tratamiento de la leishmaniasis en los cánidos. Se describe la utilización combinada del colesterol y la fosfatidilserina en la fabricación de medicamentos para el tratamiento de la leishmaniasis canina. Dicha combinación resulta eficaz por sí sola en el tratamiento de los animales afectados por la mencionada enfermedad y además, cuando se utiliza de forma combinada con otros tratamientos convencionales, especialmente con compuestos antimoniales y alopurinol, resulta ser altamente efectiva.Use of cholesterol and phospholipids in medications for the treatment of leishmaniasis in canids. The combined use of cholesterol and phosphatidylserine in the manufacture of medicaments for the treatment of canine leishmaniasis is described. This combination is effective in itself in the treatment of animals affected by the aforementioned disease and also, when used in combination with other conventional treatments, especially with antimonial compounds and allopurinol, it is highly effective.

ES200102260A 2001-10-10 2001-10-10 USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS. Expired - Fee Related ES2184650B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200102260A ES2184650B1 (en) 2001-10-10 2001-10-10 USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200102260A ES2184650B1 (en) 2001-10-10 2001-10-10 USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS.

Publications (2)

Publication Number Publication Date
ES2184650A1 ES2184650A1 (en) 2003-04-01
ES2184650B1 true ES2184650B1 (en) 2004-09-16

Family

ID=8499152

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200102260A Expired - Fee Related ES2184650B1 (en) 2001-10-10 2001-10-10 USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS.

Country Status (1)

Country Link
ES (1) ES2184650B1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302459A (en) * 1980-03-19 1981-11-24 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
PT1019417E (en) * 1997-08-18 2003-03-31 Max Planck Ges Zur Forderung W PHOSPHOLIPID ANALYSIS COMPOUNDS
DE10015814A1 (en) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Medicines to stimulate leukopoiesis, treat tumors and protozoan diseases and process for its manufacture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALVING, C.R. et al.: "Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs", P.N.A.S. U.S.A. (1978), 75 (6), páginas 2959-63, ISSN: 0027-8424, todo el documento. *

Also Published As

Publication number Publication date
ES2184650A1 (en) 2003-04-01

Similar Documents

Publication Publication Date Title
BR122014006936B8 (en) pharmaceutical composition comprising in the form of an intravaginal ring
UY28757A1 (en) SUBSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
UY27511A1 (en) NEW ANDIDIABÉTIC AGENTS
ITPD20020246A1 (en) STRUCTURE OF WATERPROOF AND BREATHABLE SOLE FOR FOOTWEAR AND FOOTWEAR MADE WITH THE SOLE.
ECSP055747A (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS
AR037109A1 (en) USE OF FLIBANSERINE
BRPI0308360B8 (en) thermosensitive composition in liquid form comprising organogelling substance, use of a composition and process for preparing a composition
GT200200188A (en) PREPARATION AND USE OF IMIDAZOL DERIVATIVES FOR THE TREATMENT OF OBESITY
GT199900203A (en) CELECOXIB COMPOSITIONS.
CY1110019T1 (en) Combined Therapy with Substituted Oxazolidinones
UY28040A1 (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS.
CL2003002767A1 (en) ORAL COMPOSITION THAT INCLUDES A FILM CONTAINING A FUNCTIONAL MATERIAL, IN A VEHICLE, USEFUL FOR ORAL CARE.
BR9910490A (en) Materials and methods for creating insects, mites and other beneficial organisms
MX9307885A (en) APPLICATION OF CARBAMZAEPINE AND OXCARBAZEPIAN TO OBTAIN MEDICINES FOR THE TREATMENT OF PARKINSON DISEASE AND PARKINSONIAN SYNDROMES.
ECSP045353A (en) DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND APPLICATION AS MEDICATIONS
BRPI0415713A (en) myo-inositol hexaphosphate for topical use
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
DE602006009259D1 (en) PHARMACEUTICAL COMPOSITION COMPRISING ORGANIC ORGANIC FUEL
ATE413399T1 (en) MORPHOLINYL UREA DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH INFLAMMATORY PROCESSES
DK1713438T3 (en) Medical soap
ES2184650B1 (en) USE OF CHOLESTEROL AND PHOSPHOLIPIDS IN MEDICINES FOR THE TREATMENT OF LEISHMANIASIS IN LOS CANIDOS.
AR036877A1 (en) PHARMACEUTICAL FORMULATION
CO5261531A1 (en) PLEUROMUTILINE AND VALNEMULIN DERIVATIVES USED FOR THE MANUFACTURE OF A MEDICINAL PRODUCT IN THE TRANSDERMAL TREATMENT OF BACTERIAL INFECTIONS IN HUMANS AND ANIMALS AND COMPOSITION CONTAINING THEM
BR0210632A (en) Parasitic disease treatment
RU2002107079A (en) Sedative

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030401

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2184650B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807